STOCK TITAN
  1. Home
  2. News
  3. RHHBY

Roche Holding AG - RHHBY STOCK NEWS

IMPACT
SENTIMENT
RHHBY : OTC
Roche’s Vabysmo maintained vision improvements with extended treatment intervals up to four months for people with retinal vein occlusion (RVO) in phase III studies
clinical trial
IMPACT
SENTIMENT
RHHBY : OTC
Genentech’s Vabysmo Maintained Vision Improvements With Extended Treatment Intervals Up to Four Months for People With Retinal Vein Occlusion (RVO) in Phase III Trials
clinical trial
IMPACT
SENTIMENT
RHHBY : OTC
Majority of newborn babies with spinal muscular atrophy (SMA) treated with Roche’s Evrysdi able to sit independently after 1 year of treatment
IMPACT
SENTIMENT
RHHBY : OTC
Majority of Newborn Babies With Spinal Muscular Atrophy (SMA) Treated With Genentech’s Evrysdi Able to Sit Independently After 1 Year of Treatment
IMPACT
SENTIMENT
RHHBY : OTC
Roche to present new key clinical and real-world data at ECTRIMS-ACTRIMS 2023 showcasing strength of long-term outcomes in MS and NMOSD
conferences
IMPACT
SENTIMENT
RHHBY : OTC
Genentech to Present New Key Clinical and Real-world Data at ECTRIMS-ACTRIMS 2023 Showcasing Strength of Long-term Outcomes in MS and NMOSD
conferences
IMPACT
SENTIMENT
RHHBY : OTC
Roche and Alnylam report positive topline results from Phase 2 study KARDIA-1 of zilebesiran, an investigational RNAi therapeutic in development to treat hypertension in patients at high risk of cardiovascular disease
clinical trial
IMPACT
SENTIMENT
RHHBY : OTC
FDA Accepts Application for Genentech’s Crovalimab for the Treatment of PNH, a Rare Life-Threatening Blood Condition
clinical trial
IMPACT
SENTIMENT
RHHBY : OTC ROG : NYSE RHHBF : OTC
Economist Impact report, Advancing the frontier of health and technology integration: The 2023 Digital Health Barometer highlights opportunities in digitalisation of healthcare
IMPACT
SENTIMENT
RHHBY : OTC
Genentech’s Alecensa Delivers Unprecedented Phase III Results for People With ALK-Positive Early-Stage Lung Cancer
clinical trial
Stock RHHBY logo
Roche Holding AG

OTC:RHHBY

RHHBY Rankings

#37 Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

RHHBY Stock Data

Medicinal and Botanical Manufacturing
Manufacturing
Pharmaceuticals: Major, Health Technology, Manufacturing, Medicinal and Botanical Manufacturing
Switzerland
Basel